Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals


Por: Matthews, R, Armstrong, AW, Augustin, M, Baker, C, Carrascosa, JM, Kirby, B, Langley, R, McBride, S, Reich, A, Romiti, R, Sampogna, F and Warren, RB

Publicada: 1 ene 2026 Ahead of Print: 1 nov 2025
Resumen:
IntroductionDelays remain in patients receiving effective treatment strategies that have potential to clear their skin of psoriasis, improve their quality of life (QoL) and change the psoriatic disease course, which, if uncontrolled, can irreversibly alter an individual's life course (i.e. cumulative life course impairment [CLCI]). This study explored current international awareness and consideration of the potential impact of psoriasis over the life course within clinical assessments and decisions about its management.MethodsCross-sectional surveys collated insights from people with psoriasis and healthcare professionals (HCPs) treating psoriasis (dermatologists and primary care physicians [PCPs]) across 29 countries.ResultsData were collected from 487 people with psoriasis, 574 dermatologists and 618 PCPs. Despite people with psoriasis highlighting a range of daily activities that are 'very frequently' or 'always' affected by their psoriasis, 37% were never or rarely asked by their HCPs how the disease affects their life. Fewer than half of people with psoriasis had a high understanding of the potential future impact of psoriasis (or CLCI-contributing factors), and 44% were unaware that clear/almost clear skin is now a realistic treatment target. Almost half of HCPs considered psoriasis to be of early onset when it presented at <= 15 years of age. Despite HCP awareness of the impact of psoriasis on QoL, many of the contributing factors to CLCI were not addressed routinely in clinical practice nor considered when deciding on treatment; 40% of dermatologists set treatment goals (such as clear skin/almost clear skin/target Dermatology Life Quality Index [DLQI]) sometimes, less frequently, or not at all.ConclusionsMisalignment exists in the experience of people living with psoriasis versus its assessment in clinical practice. Support is needed for assessment and monitoring of elements that may contribute to CLCI in clinical practice worldwide, to guide early psoriasis treatment decision-making to mitigate the risk for CLCI.Infographic available for this article.ConclusionsMisalignment exists in the experience of people living with psoriasis versus its assessment in clinical practice. Support is needed for assessment and monitoring of elements that may contribute to CLCI in clinical practice worldwide, to guide early psoriasis treatment decision-making to mitigate the risk for CLCI.Infographic available for this article.

Filiaciones:
Matthews, R:
 Univ Manchester, Northern Care Alliance NHS Fdn Trust, Manchester NIHR Biomed Res Ctr, Manchester Acad Hlth Sci Ctr,Dermatol Ctr, Manchester, England

 Univ Manchester, Manchester NIHR Biomed Res Ctr, Manchester Acad Hlth Sci Ctr, Div Musculoskeletal & Dermatol Sci, Manchester, England

Armstrong, AW:
 Univ Calif Los Angeles, Div Dermatol, Los Angeles, CA USA

Augustin, M:
 Univ Med Ctr Hamburg, Inst Hlth Serv Res Dermatol & Nursing, Hamburg, Germany

Baker, C:
 Univ Melbourne, Vincents Hosp Melbourne, Melbourne, Australia

:
 Univ Autonoma Barcelona, Hosp Univ Germans Trias I Pujol HUGiT, Serv Dermatol, Badalona, Spain

Kirby, B:
 Univ Coll Dublin, Dublin, Ireland

Langley, R:
 Dalhousie Univ, Halifax, NS, Canada

 Nova Scotia Hlth, Halifax, NS, Canada

McBride, S:
 Royal Free London NHS Fdn Trust, London, England

Reich, A:
 Univ Rzeszow, Med Coll Rzeszow, Dept Dermatol, Rzeszow, Poland

Romiti, R:
 Univ Sao Paulo, Dept Dermatol, Sao Paulo, SP, Brazil

Sampogna, F:
 Ist Dermopat Immacolata IDI IRCCS, Clin Epidemiol Unit, Rome, Italy

Warren, RB:
 Univ Manchester, Northern Care Alliance NHS Fdn Trust, Manchester NIHR Biomed Res Ctr, Manchester Acad Hlth Sci Ctr,Dermatol Ctr, Manchester, England

 Univ Manchester, Manchester NIHR Biomed Res Ctr, Manchester Acad Hlth Sci Ctr, Div Musculoskeletal & Dermatol Sci, Manchester, England
ISSN: 21938210





Dermatology and Therapy
Editorial
Springer Verlag, 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND, Reino Unido
Tipo de documento: Article
Volumen: 16 Número: 1
Páginas: 499-520
WOS Id: 001620115400001
ID de PubMed: 41273665
imagen Green Submitted, gold

MÉTRICAS